Drugs that contain Emtricitabine; Tenofovir Alafenamide Fumarate

1. Drug name - DESCOVY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7390791 GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues
Apr, 2025

(2 years from now)

US8754065 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

US9296769 GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

CN1706855A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100402539C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1443189A GILEAD SCIENCES INC Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN241597B GILEAD SCIENCES INC Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN208435B GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397A1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 GILEAD SCIENCES INC Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2744810B1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810A1 GILEAD SCIENCES INC Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7390791

(Pediatric)

GILEAD SCIENCES INC Prodrugs of phosphonate nucleotide analogues Oct, 2025

(3 years from now)

US9296769

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

US8754065

(Pediatric)

GILEAD SCIENCES INC Tenofovir alafenamide hemifumarate Feb, 2033

(10 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
120MG;EQ 15MG BASE TABLET;ORAL Prescription
200MG;EQ 25MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.